In our study, 1 we quantified the contribution of smooth muscle cells and myeloid-lineage cells to the total foam cell population in atherosclerosis. To do so, we analyzed foam cell-rich lesions, which for that part of our study were selected from types II and III (ie, intermediate stage) atherosclerosis. Measuring the cholesterol level of different stage lesions was beyond the scope of this study; however, a key feature of advancing atherosclerosis is the expansion of the lipid-rich necrotic core thought to arise from the death of lipidladen foam cells. Our results indicate that at least 50% of the foam cells contributing to the progression of lesions and likely necrosis are smooth muscle cell derived. Our lipid fixation method was adapted from 2 plainly cited articles by Tracy and Wallia, which described the technique exclusively in human, not mouse, tissues. We firmly disagree with Kumar that our method of delineating intracellular and extracellular lipid is flawed. The images clearly define extracellular lipids not contained within smooth muscle cells in early lesions, and foam cells with intracellular lipid droplets in intermediate-stage atherosclerosis. Immunostaining is a widely used and accepted technique to identify cell-specific markers, in this case SM α-actin, which is not expressed by myeloid-lineage cells, and CD45, which is not expressed by smooth muscle cells. The use of a lineage-specific marker to identify smooth muscle cells lacking SM α-actin expression has not been performed along with colocalization of intracellular lipids, and would be difficult owing to the very discrete nature of the lineage marker. 2 If possible, this would only increase the estimated contribution of smooth muscle cells to the foam cell population. We routinely perform isotype-matched controls to rule out false-positive antibody staining, but did not include these images because of space limitations. We are embarking on fluorescence-activated cell sorting analysis of atherosclerotic coronary arteries, and expect this will increase the estimate of the contribution of smooth muscle cells to total foam cells. Neointima is the term reserved for new intima formed after direct arterial injury such as angioplasty, or following cardiac allografting. We indicated clearly that the lesions studied in our article were native atherosclerosis, not postangioplasty or posttransplant. We quantitated the reduction in ATP-binding cassette transporter A1 (ABCA1) expression in intimal in comparison with medial smooth muscle cells in our 2009 publication. 3 Examining the expression of ABCA1 in early and late lesion smooth muscle cells and myeloid-lineage cells was a direct extension of these findings, and was important to see whether there was a similar loss of ABCA1 expression in early or late lesion myeloid-lineage cells. We did not find a reduction of ABCA1 expression in the myeloid-lineage cells, providing what we feel is a highly plausible explanation for the large contribution of smooth muscle cells to the total foam cell population and reduced ABCA1 expression and activity. We state clearly in the article that this is 1 possible explanation for the findings. It has been previously shown, however, that ABCA1 protein levels correlate directly with cholesterol efflux, the main function of ABCA1. 4
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